BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1660692)

  • 1. A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates.
    Rialet V; Meijer L
    Anticancer Res; 1991; 11(4):1581-90. PubMed ID: 1660692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase.
    Baratte B; Meijer L; Galaktionov K; Beach D
    Anticancer Res; 1992; 12(3):873-80. PubMed ID: 1320360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From ovocyte to biochemistry of the cell cycle].
    Ozon R
    Verh K Acad Geneeskd Belg; 1991; 53(4):365-85. PubMed ID: 1659057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components.
    Pondaven P; Meijer L; Beach D
    Genes Dev; 1990 Jan; 4(1):9-17. PubMed ID: 2155162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of MPF and histone H1 kinase activity differ during the G2- to M-phase transition in mouse oocytes.
    Jung T; Moor RM; Fulka J
    Int J Dev Biol; 1993 Dec; 37(4):595-600. PubMed ID: 8180003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase.
    Meijer L; Arion D; Golsteyn R; Pines J; Brizuela L; Hunt T; Beach D
    EMBO J; 1989 Aug; 8(8):2275-82. PubMed ID: 2551679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2.
    Azzi L; Meijer L; Reed SI; Pidikiti R; Tung HY
    Eur J Biochem; 1992 Feb; 203(3):353-60. PubMed ID: 1310466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M-phase-specific histone H1 kinase in fish oocytes. Purification, components and biochemical properties.
    Yamashita M; Fukada S; Yoshikuni M; Bulet P; Hirai T; Yamaguchi A; Yasuda H; Ohba Y; Nagahama Y
    Eur J Biochem; 1992 Apr; 205(2):537-43. PubMed ID: 1315270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-cycling mitotic cyclin in the naturally synchronous cell cycle of Physarum polycephalum.
    Cho JW; Sauer HW
    Eur J Cell Biol; 1994 Oct; 65(1):94-102. PubMed ID: 7889999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A versatile microtiter assay for the universal cdc2 cell cycle regulator.
    Ducommun B; Beach D
    Anal Biochem; 1990 May; 187(1):94-7. PubMed ID: 2164794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPF components and meiotic competence in growing pig oocytes.
    Christmann L; Jung T; Moor RM
    Mol Reprod Dev; 1994 May; 38(1):85-90. PubMed ID: 8049069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF.
    Arion D; Meijer L; Brizuela L; Beach D
    Cell; 1988 Oct; 55(2):371-8. PubMed ID: 2844417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK inactivation is required for the G2 to M-phase transition of the first mitotic cell cycle.
    Abrieu A; Fisher D; Simon MN; Dorée M; Picard A
    EMBO J; 1997 Nov; 16(21):6407-13. PubMed ID: 9351823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin B targets p34cdc2 for tyrosine phosphorylation.
    Meijer L; Azzi L; Wang JY
    EMBO J; 1991 Jun; 10(6):1545-54. PubMed ID: 1709096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activity of p27kip1 and its amino- and carboxy-terminal domains in G2/M transition of Xenopus oocytes.
    Font de Mora J; Uren A; Heidaran M; Santos E
    Oncogene; 1997 Nov; 15(21):2541-51. PubMed ID: 9399642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiophosphorylated RCM-lysozyme, an active site-directed protein tyrosine phosphatase inhibitor, inhibits G2/M transition during mitotic cell cycle and uncouples MPF activation from G2/M transition.
    Hiriyanna KT; Buck WR; Shen SS; Ingebritsen TS
    Exp Cell Res; 1995 Jan; 216(1):21-9. PubMed ID: 7813623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle.
    Gautier J; Matsukawa T; Nurse P; Maller J
    Nature; 1989 Jun; 339(6226):626-9. PubMed ID: 2543932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the function of the cdc2 kinase subunit proteins tuned by their propensities to oligomerize? Conformational states in solution of the cdc2 kinase partners p13suc1 and p9cksphy.
    Birck C; Vachette P; Welch M; Swarén P; Samama JP
    Biochemistry; 1996 Apr; 35(17):5577-85. PubMed ID: 8611549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p13suc1 suppresses the catalytic function of p34cdc2 kinase for intermediate filament proteins, in vitro.
    Kusubata M; Tokui T; Matsuoka Y; Okumura E; Tachibana K; Hisanaga S; Kishimoto T; Yasuda H; Kamijo M; Ohba Y
    J Biol Chem; 1992 Oct; 267(29):20937-42. PubMed ID: 1400409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.